Abele, M., Riet, A., Hummel, T., Klockgether, T., Wullner, U. 2003.Olfactory dysfunction in cerebellar ataxia and multiple system atrophy. Journal of Neurology 250, 1453–1455.CrossRefGoogle ScholarPubMed

Adler, C.H., Caviness, J.N., Sabbagh, M.N., et al. 2005. Olfactory testing in Parkinson’s disease and other movement disorders: Correlation with Parkinsonian severity. Movement Disorders 20(Supplement 10), Abs: 231.Google Scholar

Aggarwal, N.T., Bienias, J.L., Bennett, D.A., et al. 2006. The relation of cigarette smoking to incident Alzheimer’s disease in a biracial urban community population. Neuroepidemiology 26(3), 140–146.CrossRefGoogle Scholar

Ahlskog, J.E., Waring, S.C., Petersen, R.C., et al. 1998. Olfactory dysfunction in Guamanian ALS, parkinsonism, and dementia. Neurology 51, 1672–1677.CrossRefGoogle ScholarPubMed

Alcalay, R.N., Siderowf, A., Ottman, R., et al. 2011. Olfaction in Parkin heterozygotes and compound heterozygotes: The CORE-PD study. Neurology 76, 319–326.CrossRefGoogle ScholarPubMed

Altinayar, S., Oner, S., Can, S., Kizilay, A., Sarac, K., 2014. Olfactory disfunction and its relation olfactor bulbus volume in Parkinson’s disease. European Review for Medical and Pharmacological Sciences 18(23), 3659–3664.Google Scholar

Altschuler, E., 1996. Gastric Helicobacter pylori infection as a cause of idiopathic Parkinson disease and non-arteric anterior optic ischemic neuropathy. Medical Hypotheses 47(5), 413–414.CrossRefGoogle ScholarPubMed

Ansari, K.A., Johnson, A., 1975. Olfactory function in patients with Parkinson’s disease. Journal of Chronic Diseases 28, 493–497.CrossRefGoogle ScholarPubMed

Antunes, M., Bowler, R.M., Doty, R.L., 2007. San Francisco/Oakland Bay Bridge Welder Study: Olfactory function. Neurology 69, 1278–1284.CrossRefGoogle ScholarPubMed

Armstrong, C., Harrison, W.T., 1935. Prevention of intranasally-inoculated poliomyelitis of monkeys by instillation of alum into the nostrils. Public Health Reports 50, 725–730.CrossRefGoogle Scholar

Arriagada, P.V., Louis, D.N., Hedley-Whyte, E.T., Hyman, B.T., 1991. Neurofibrillary tangles and olfactory dysgenesis. Lancet 337, 559.CrossRefGoogle ScholarPubMed

Ascherio, A., Chen, H., Weisskopf, M.G., et al. 2006. Pesticide exposure and risk for Parkinson’s disease. Annals of Neurology 60, 197–203.CrossRefGoogle ScholarPubMed

Attems, J., Lintner, F., Jellinger, K.A., 2005. Olfactory involvement in aging and Alzheimer’s disease: an autopsy study. Journal of Alzheimer’s Disease 7(2), 149–157.CrossRefGoogle ScholarPubMed

Bacon, A.W., Bondi, M.W., Salmon, D.P., Murphy, C., 1998. Very early changes in olfactory functioning due to Alzheimer’s disease and the role of apolipoprotein E in olfaction. Annals of the New York Academy of Sciences 855, 723–731.CrossRefGoogle ScholarPubMed

Bahar-Fuchs, A., Moss, S., Rose, C., Savage, G., 2010. Olfactory performance in AD, aMCI, and healthy aging: A unirhinal approach. Chemical Senses 35, 855–862.CrossRefGoogle ScholarPubMed

Bak, T.H., Chandran, S., 2011. What wires together dies together: Verbs, actions and neurodegeneration in motor neuron disease. Cortex 48, 936–944.CrossRefGoogle ScholarPubMed

Baker, K.B., Montgomery, E.B. Jr, 2001. Performance on the PD test battery by relatives of patients with progressive supranuclear palsy. Neurology 56, 25–30.CrossRefGoogle ScholarPubMed

Bakija-Konsuo, A., Mulic, R., Boraska, V., et al. 2011. Leprosy epidemics during history increased protective allele frequency of PARK2/PACRG genes in the population of the Mljet Island, Croatia. European Journal of Medical Genetics 54, e548–e552.Google ScholarPubMed

Ball, M.J., Nuttall, K., 1980. Neurofibrillary tangles granulovacuolar degeneration and neuron loss in Down’s syndrome: Quantitative comparison with Alzheimer’s dementia. Annals of Neurology 7, 462–465.CrossRefGoogle Scholar

Ballard, C., Ziabreva, I., Perry, R., et al. 2006. Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 67, 1931–1934.CrossRefGoogle ScholarPubMed

Bannier, S., Berdague, J.L., Rieu, I., et al. 2012. Prevalence and phenomenology of olfactory hallucinations in Parkinson’s disease. Journal of Neurology, Neurosurgery, & Psychiatry 83, 1019–1021.CrossRefGoogle ScholarPubMed

Barnett, E.M., Cassell, M.D., Perlman, S., 1993. Two neurotropic viruses, herpes simplex virus type 1 and mouse hepatitis virus, spread along different neural pathways from the main olfactory bulb. Neuroscience 57, 1007–1025.CrossRefGoogle ScholarPubMed

Barrios, F.A., Gonzalez, L., Favila, R., et al. 2007. Olfaction and neurodegeneration in HD. Neuroreport 18, 73–76.CrossRefGoogle ScholarPubMed

Bar-Sela, S., Reingold, S., Richter, E.D., 2001. Amyotrophic lateral sclerosis in a battery-factory worker exposed to cadmium. International Journal of Occupational and Environmental Health 7, 109.CrossRefGoogle Scholar

Barz, S., Hummel, T., Pauli, E., et al. 1997. Chemosensory event-related potentials in response to trigeminal and olfactory stimulation in idiopathic Parkinson’s disease. Neurology 49, 1424–1431.CrossRefGoogle ScholarPubMed

Beach, T.G., White, C.L. 3rd, Hladik, C.L., et al. 2009. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathologica 117(2), 169–174.CrossRefGoogle ScholarPubMed

Beavan, M., McNeill, A., Proukakis, C., et al. 2015. Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort. JAMA Neurology 72, 201–208.CrossRefGoogle Scholar

Bedard, A., Parent, A., 2004. Evidence of newly generated neurons in the human olfactory bulb. Developmental Brain Research 151, 159–168.CrossRefGoogle ScholarPubMed

Belluscio, L., Gold, G.H., Nemes, A., Axel, R., 1998. Mice deficient in G(olf) are anosmic. Neuron 20, 69–81.CrossRefGoogle Scholar

Belzunegui, S., Sebastian, W.S., Garrido-Gil, P., 2007. The number of dopaminergic cells is increased in the olfactory bulb of monkeys chronically exposed to MPTP. Synapse 61, 1006–1012.CrossRefGoogle ScholarPubMed

Berendse, H.W., Roos, D.S., Raijmakers, P., Doty, R.L., 2011. Motor and non-motor correlates of olfactory dysfunction in Parkinson’s disease. Journal of the Neurological Sciences 310, 21–24.CrossRefGoogle ScholarPubMed

Berger, P.C., Vogel, F.S., 1973. The development of the pathologic changes of Alzheimer’s disease and senile dementia in patients with Down’s syndrome. American Journal of Pathology 73, 457–476.Google Scholar

Bessen, R.A., Shearin, H., Martinka, S., et al. 2010. Prion shedding from olfactory neurons into nasal secretions. PLoS Pathogens 6, e1000837.CrossRefGoogle ScholarPubMed

Bessen, R.A., Wilham, J.M., Lowe, D., Watschke, C.P., Shearin, H., Martinka, S., Caughey, B., Wiley, J.A., 2011. Accelerated shedding of prions following damage to the olfactory epithelium. Journal of Virology 86(3), 1777–1788.CrossRefGoogle Scholar

Betarbet, R., Sherer, T.B., MacKenzie, G., et al. 2000. Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nature Neuroscience 3, 1301–1306.CrossRefGoogle ScholarPubMed

Boesveldt, S., Verbaan, D., Knol, D.L., et al. 2008. A comparative study of odor identification and odor discrimination deficits in Parkinson’s disease. Movement Disorders 23, 1984–1990.CrossRefGoogle ScholarPubMed

Boeve, B.F., Silber, M.H., Parisi, J.E., et al. 2003. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology 61, 40–45.CrossRefGoogle ScholarPubMed

Bogerts, B., Hantsch, J., Herzer, M., 1983. A Morphometric Study of the Dopamine-Containing Cell Groups in the Mesencephalon of Normals, Parkinson Patients, and Schizophrenics. Biological Psychiatry 18, 951–969.Google ScholarPubMed

Bohnen, N.I., Gedela, S., Herath, P., Constantine, G.M., Moore, R.Y., 2008. Selective hyposmia in Parkinson disease: association with hippocampal dopamine activity. Neuroscience Letters 447, 12–16.CrossRefGoogle ScholarPubMed

Bohnen, N.I., Gedela, S., Kuwabara, H., et al. 2007. Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson’s disease. Journal of Neurology 254, 84–90.CrossRefGoogle ScholarPubMed

Bohnen, N.I., Muller, M.L., Kotagal, V., et al. 2010. Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson’s disease. Brain 133, 1747–1754.CrossRefGoogle ScholarPubMed

Bond, J.A., 1986. Bioactivation and biotransformation of xenobiotics in rat nasal tissue. In: Toxicology of the Nasal Passages. Ed. Barrow, C.S.. Washington DC: Hemisphere Publishing Corporation pp. 249–261.Google Scholar

Bostantjopoulou, S., Katsarou, Z., Papadimitriou, A., et al. 2001. Clinical features of parkinsonian patients with the alpha-synuclein (G209A) mutation. Movement Disorders 16, 1007–1013.CrossRefGoogle ScholarPubMed

Bovi, T., Antonini, A., Ottaviani, S., et al. 2010. The status of olfactory function and the striatal dopaminergic system in drug-induced parkinsonism. Journal of Neurology 257, 1882–1889.CrossRefGoogle ScholarPubMed

Bower, J.H., Maraganore, D.M., Peterson, B.J., Ahlskog, J.E., Rocca, W.A., 2006. Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study. Neurology 67, 494–496.CrossRefGoogle ScholarPubMed

Braak, H., Braak, E., 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica 82(4), 239–259.CrossRefGoogle ScholarPubMed

Braak, H., Braak, E., 1998. Evolution of neuronal changes in the course of Alzheimer’s disease. Journal of Neural Transmission 53, 127–140.CrossRefGoogle ScholarPubMed

Braak, H., de Vos, R.A., Bohl, J., Del Tredici, K., 2006. Gastric α-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology. Neuroscience Letters 396(1), 67–72.CrossRefGoogle ScholarPubMed

Braak, H., Del Tredici, K., 2011. The pathological process underlying Alzheimer’s disease in individuals under thirty. Acta Neuropathologica 121, 171–181.CrossRefGoogle ScholarPubMed

Braak, H., Del Tredici, K., Rub, U., et al. 2003a. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiology of Aging 24, 197–211.CrossRefGoogle ScholarPubMed

Braak, H., Rub, U., Gai, W.P., Del Tredici, K. 2003b. Idiopathic Parkinson’s disease: Possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. Journal of Neural Transmission 110, 517–536.CrossRefGoogle ScholarPubMed

Braak, H., Thal, D.R., Ghebremedhin, E., Del, T.K., 2011. Stages of the pathologic process in Alzheimer disease: Age categories from 1 to 100 years. Journal of Neuropathology and Experimental Neurology 70, 960–969.CrossRefGoogle ScholarPubMed

Braga-Neto, P., Felicio, A.C., Pedroso, J.L., et al. 2011. Clinical correlates of olfactory dysfunction in spinocerebellar ataxia type 3. Parkinsonism & Related Disorders 17, 353–356.CrossRefGoogle ScholarPubMed

Branco Germiniani, F., Cavalcante, T., Moro, A., et al. 2014. Evaluation of olfactory function in Friedreich’s ataxia: A case-control study. European Journal of Neurology 21, 175–175.Google Scholar

Brittebo, E.B., Eriksson, V.F., Bakke, J., Brandt, I., 1991. Toxicity of 2 6-dichlorothiobenzamide (Chlorthiamid) and 2 6-dichlorobenzamide in the olfactory nasal mucosa of mice. Fundamental and Applied Toxicology 17, 92–102.CrossRefGoogle Scholar

Brodoehl, S., Klingner, C., Volk, G.F., et al. 2012. Decreased olfactory bulb volume in idiopathic Parkinson’s disease detected by 3.0-Tesla magnetic resonance imaging. Movement Disorders 27, 1019–1025.CrossRefGoogle Scholar

Broggio, E., Pluchon, C., Ingrand, P., Gil, R., 2001. Taste impairment in Alzheimer’s disease. Revue Neurologique 157(4), 409–413.Google ScholarPubMed

Brousseau, K., Brainerd, H.G., Mongolism: A Study of the Physical and Mental Characteristics of Mongolian Imbeciles. Baltimore: Williams and Wilkins. 1928.CrossRefGoogle Scholar

Busenbark, K.L., Huber, S.J., Greer, G., Pahwa, R., Koller, W.C., 1992. Olfactory function in essential tremor. Neurology 42, 1631–1632.CrossRefGoogle ScholarPubMed

Buxton, P.H., Hayward, M., 1967. Polyneuritis cranialis associated with industrial trichloroethylene exposure. Journal of Neurology, Neurosurgery, & Psychiatry 30, 511–518.CrossRefGoogle Scholar

Bylsma, F.W., Moberg, P.J., Doty, R.L., Brandt, J., 1997. Odour identification in Huntington’s disease patients and their offspring with and without the genetic mutation for HD. Journal of Neuropsychology and Clinical Neuroscience 9, 598–600Google Scholar

Calderón-Garcidueñas, L., Reed, W., Maronpot, R.R., et al. 2004. Brain inflammation and Alzheimer’s-like pathology in individuals exposed to severe air pollution. Toxicologic Pathology 32(6), 650–658.CrossRefGoogle ScholarPubMed

Calderón-Garcidueñas, L., Franco-Lira, M., Henríquez-Roldán, C., et al. 2010. Urban air pollution: Influences on olfactory function and pathology in exposed children and young adults. Experimental and Toxicologic Pathology 62(1), 91–102.CrossRefGoogle ScholarPubMed

Charles, P.C., Walters, E., Margolis, F., Johnston, R.E., 1995. Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse. Virology 208, 662–671.CrossRefGoogle ScholarPubMed

Chen, M.A., Lander, T.R., Murphy, C., 2006. Nasal health in Down syndrome: A cross-sectional study. Otolaryngology – Head and Neck Surgery 134, 741–745.CrossRefGoogle ScholarPubMed

Chen, S., Tan, H.Y., Wu, Z.H., et al. 2014. Imaging of olfactory bulb and gray matter volumes in brain areas associated with olfactory function in patients with Parkinson’s disease and multiple system atrophy. European Journal of Radiology 83, 564–570.CrossRefGoogle ScholarPubMed

Connelly, T., Farmer, J., Lunch, D., Doty, R.L., 2003. Olfactory dysfunction in degenerative ataxias. Journal of Neurology, Neurosurgery, & Psychiatry 74(10), 1435–1437.CrossRefGoogle ScholarPubMed

Constantinidis, J., de Ajuriaguerra, J., 1970. Syndrome familial avec tremblement parkin-sonien et anosmie et sa thérapeutique par la L-dopa associée à un inhibiteur de la decarboxylase. Thérapeutique (Semaine des Hôpitaux), 46, 263–269.Google Scholar

Crino, P.B., Martin, J.A., Hill, W.D., et al. 1995. Beta-amyloid peptide and amyloid precursor proteins in olfactory mucosa of patients with Alzheimer’s disease Parkinson’s disease and Down syndrome. Annals of Otology, Rhinology, and Laryngology 104, 655–661.CrossRefGoogle ScholarPubMed

Dahl, A.R., 1986. Possible consequences of cytochrome P-450 dependent monooxygenases in nasal tissues. In: Toxicology of the Nasal Passages. Ed. Barrow, C.S. Hemisphere Publishing Corporation. Washington D.C.; 263–273.Google Scholar

Dahl, A.R., 1988. The effect of cytochrome P-450-dependent metabolism and other enzyme activities in olfaction. In: Molecular Neurobiology of the Olfactory System. Eds. Margolis, F.L., Getchell, T.V. Plenum press. New York; 51–70.CrossRefGoogle Scholar

Daniel, S.E., Hawkes, C.H., 1992. Preliminary diagnosis of Parkinson’s disease by olfactory bulb pathology [letter]. Lancet 340, 186.CrossRefGoogle ScholarPubMed

Daum, R.F., Sekinger, B., Kobal, G., Lang, C.J., (2000) Riechprufung mit “sniffin’ sticks” zur klinischen Diagnostik des Morbus Parkinson. Nervenarzt 71, 643–650.CrossRefGoogle Scholar

Deeb, J., Shah, M., Muhammed, N., et al. 2010. A basic smeel test is as sensitive as a dopamine transporter scan: Comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson’s disease. QJM 103, 941–952.CrossRefGoogle Scholar

Del Tredici, K., Hawkes, C.H., Ghebremedhin, E., Braak, H., 2010. Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease. Acta Neuropathologica 119, 703–713.CrossRefGoogle ScholarPubMed

Devanand, D.P., Liu, X., Tabert, M.H., et al. 2008. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer’s disease. Biological Psychiatry 64(10), 871–879.CrossRefGoogle ScholarPubMed

Devanand, D.P., Michaels-Marston, K.S., Liu, X., et al. 2000. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer’s disease at follow-up. American Journal of Psychiatry 157, 1399–1405.CrossRefGoogle ScholarPubMed

Diaz-Maroto, M.C., Perez-Coello, M.S., Cabezudo, M.D., 2002. Headspace solid-phase microextraction analysis of volatile components of spices. Chromatographia, 55, 723–728.CrossRefGoogle Scholar

Ding Xie, F., 2015, Olfactory mucosa: Composition, enzymatic localization, and metabolism. In Doty, R.L., (Ed.), Handbook of Olfaction and Gustation. Hoboken: John Wiley & Sons, pp. 63–91.CrossRefGoogle Scholar

Djaldetti, R., Nageris, B.I., Lorberboym, M., et al. 2008 [(123)I]-FP-CIT SPECT and olfaction test in patients with combined postural and rest tremor. Journal of Neural Transmission 115: 469–472.CrossRefGoogle Scholar

Doty, R.L., 1991, Olfactory dysfunction in neurodegenerative disorders. In: Getchell, T.V., Doty, R.L., Bartoshuk, L.M., Snow, J.B. Jr Smell and Taste in Health and Disease. New York: Raven Press, pp. 735–752.Google Scholar

Doty, R.L., 2001, Olfaction. Annual Review of Psychology 52, 423–452.CrossRefGoogle ScholarPubMed

Doty, R.L., 2008. The olfactory vector hypothesis of neurodegenerative disease: Is it viable? Annals of Neurology 63, 7–15.CrossRefGoogle ScholarPubMed

Doty, R.L., 2015a. Neurotoxic exposure and impairment of the chemical senses of taste and smell. Handbook of Clinical Neurology 131, 299–324.CrossRefGoogle ScholarPubMed

Doty, R.L., 2015b (Ed.), Handbook of Olfaction and Gustation. Hoboken: John Wiley & Sons.CrossRefGoogle Scholar

Doty, R.L., 2017. Olfactory dysfunction in neurological diseases: Is there a common pathological substrate? Lancet Neurology 16, 478–488.CrossRefGoogle Scholar

Doty, R.L., Bayona, E.A., Leon-Ariza, D.S., et al. 2014. The lateralized smell test for detecting Alzheimer’s disease: Failure to replicate. Journal of the Neurological Sciences 340, 170–173.CrossRefGoogle ScholarPubMed

Doty, R.L., Bromley, S.M., Moberg, P.J., Hummel, T., 1997. Laterality in human nasal chemoreception. Chapter 14. In: Christman, S. (Ed.), Cerebral Asymmetries in Sensory and Perceptual Processing. Elsevier, pp. 497–542.CrossRefGoogle Scholar

Doty, R.L., Deems, D.A., Stellar, S., 1988. Olfactory dysfunction in parkinsonism: A general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology, 38, 1237–1244.CrossRefGoogle ScholarPubMed

Doty, R.L., Golbe, L.I., McKeown, D.A., et al. 1993. Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson’s disease. Neurology, 43, 962–965.CrossRefGoogle ScholarPubMed

Doty, R.L., Hawkes, C.H., Good, K.P., Duda, J.E., 2015. Odor perception and neuropathology in neurodegenerative diseases and schizophrenia. In: Doty, R.L. (Ed.), Handbook of Olfaction and Gustation. 3rd edition. Hoboken, NJ: John Wiley & Sons, pp. 403–451.CrossRefGoogle Scholar

Doty, R.L., Nsoesie, M.T., Chung, I., et al. 2015. Taste function in early stage treated and untreated Parkinson’s disease. Journal of Neurology 262, 547–557.CrossRefGoogle ScholarPubMed

Doty, R.L., Perl, D.P., Steele, J.C., et al. 1991a. Odor identification deficit of the parkinsonism-dementia complex of Guam: Equivalence to that of Alzheimer’s and idiopathic Parkinson’s disease. Neurology 41, 77–80.CrossRefGoogle ScholarPubMed

Doty, R.L., Reyes, P.F., Gregor, T., 1987, Presence of both odor identification and detection deficits in Alzheimer’s disease. Brain Research Bulletin 18, 597–600.CrossRefGoogle ScholarPubMed

Doty, R.L., Riklan, M., Deems, D.A., Reynolds, C., Stellar, S., 1989. The olfactory and cognitive deficits of Parkinson’s disease: Evidence for independence. Annals of Neurology 25, 166–171.CrossRefGoogle ScholarPubMed

Doty, R.L., Shaman, P., Applebaum, S.L., et al. 1984. Smell identification ability: Changes with age. Science 226, 1441–1443.CrossRefGoogle ScholarPubMed

Doty, R.L., Stern, M.B., Pfeiffer, C., Gollomp, S.M., Hurtig, H.I., 1992a. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson’s disease. Journal of Neurology, Neurosurgery, & Psychiatry 55, 138–142.CrossRefGoogle ScholarPubMed

Doty, R.L., Singh, A., Tetrud, J., Langston, J.W., 1992b. Lack of major olfactory dysfunction in MPTP-induced parkinsonism. Annals of Neurology 32, 97–100.CrossRefGoogle ScholarPubMed

Doty, R.L., Tourbier, I., Ng, V., et al. 2015. Influences of hormone replacement therapy on olfactory and cognitive function in postmenopausal women. Neurobiology of Aging 36(6), 2053–2059.CrossRefGoogle ScholarPubMed

Double, K.L., Rowe, D.B., Hayes, M., et al. 2003. Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test. Archives of Neurology 60, 545–549.CrossRefGoogle ScholarPubMed

Driver-Dunckley, E., Adler, C.H., Hentz, J.G., et al. 2014. Olfactory dysfunction in incidental Lewy body disease and Parkinson’s disease. Parkinsonism & Related Disorders 20, 1260–1262.CrossRefGoogle ScholarPubMed

Duda, J.E., Noorigian, J.V., Petrovitch, H., White, L.R., Ross, W.R., 2007. Pattern of Lewy body progression suggested Braak staging system is supported by analysis of a population based cohort of patients. Movement Disorders 22: Suppl 16, LB5 (late breaking abstract).Google Scholar

Duda, J.E., Shah, U., Arnold, S.E., Lee, V.M., Trojanowski, J.Q., 1999. The expression of alpha- beta- and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases. Experimental Neurology 160: 515–522.CrossRefGoogle ScholarPubMed

Duff, K., McCaffrey, R.J., Solomon, G.S., 2002. The Pocket Smell Test: Successfully discriminating probable Alzheimer’s dementia from vascular dementia and major depression. Journal of Neuropsychiatry and Clinical Neurosciences, 14(2), 197–201.CrossRefGoogle ScholarPubMed

Dunn, L.M., 1981. Peabody Picture Vocabulary Test-Revised Manual for Forms L and M. American Guidance Service: Circle Pines, MN.Google Scholar

Dziewulska, D., Doi, H., Fasano, A., et al. 2013. Olfactory impairment and pathology in neurodegenerative disorders with brain iron accumulation. Acta Neuropathologica 126, 151–153.CrossRefGoogle ScholarPubMed

Eggers, C., Schmidt, A., Hagenah, J., et al. 2010. Progression of subtle motor signs in PINK1 mutation carriers with mild dopaminergic deficit. Neurology 74, 1798–1805.CrossRefGoogle ScholarPubMed

Elbaz, A., Levecque, C., Clavel, J., et al. 2004. CYP2D6 polymorphism pesticide exposure and Parkinson’s disease. Annals of Neurology 55(3), 430–434.CrossRefGoogle ScholarPubMed

Elian, M., 1991. Olfactory impairment in motor neuron disease: a pilot study. Journal of Neurology, Neurosurgery, & Psychiatry 54, 927–8CrossRefGoogle ScholarPubMed

Esiri, M.M., 1991. Pathology of the olfactory and taste systems. In: Getchell, T.V., Doty, R.L., Bartoshuk, L.M., Snow, J.B. Jr Smell and Taste in Health and Disease. N.Y.: Raven Press, pp. 683–701.Google Scholar

Evidente, V.G., Esteban, R.P., Hernandez, J.L., et al. 2004. Smell testing is abnormal in “lubag” or X-linked dystonia-parkinsonism: A pilot study. Parkinsonism & Related Disorders 10, 407–410.CrossRefGoogle ScholarPubMed

Faber, H.K., Silverberg, R.J., 1946. A neuropathological study of acute human polio-myelitis with special reference to the inidtial lesio and various potential portals of entry. Journal of Experimental Medicine 83, 329–353.CrossRefGoogle Scholar

Fearnley, J.M., Lees, A.J., 1991. Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain 114, 2283–2301.CrossRefGoogle ScholarPubMed

Fernandez-Ruiz, J., Diaz, R., Hall-Haro, C., et al. 2003. Olfactory dysfunction in hereditary ataxia and basal ganglia disorders. Neuroreport 14(10), 1339–1341.Google ScholarPubMed

Ferraris, A., Ialongo, T., Passali, G.C., et al. 2009. Olfactory dysfunction in Parkinsonism caused by PINK1 mutations. Movement Disorders 24(16), 2350–2357.CrossRefGoogle ScholarPubMed

Ferreira, J.J., Guedes, L.C., Rosa, M.M., et al. 2007. High prevalence of LRRK2 mutations in familial and sporadic Parkinson’s disease in Portugal. Movement Disorders, 22, 1194–1201.CrossRefGoogle ScholarPubMed

Ferreyra-Moyano, H., Barragan, E., 1989. The olfactory system and Alzheimer’s disease. International Journal of Neuroscience 49, 157–197.CrossRefGoogle ScholarPubMed

Fleming, S.M., Tetreault, N.A., Mulligan, C.K., et al. 2008. Olfactory deficits in mice overexpressing human wildtype alpha-synuclein. European Journal of Neuroscience 28, 247–256.CrossRefGoogle ScholarPubMed

Flexner, S., Clark, P.F., 1912. A note on the mode of infection in epidemic poliomyelitis. Proceedings of the Society for Experimental Biology & Medicine 10, 1–2.CrossRefGoogle Scholar

Flexner, S., Lewis, P.A., 1910. Experimental epidemic poliomyelitis in monkeys. Journal of Experimental Medicine 12, 227–255.CrossRefGoogle ScholarPubMed

Funabe, S., Takao, M., Saito, Y., et al. 2013. Neuropathologic analysis of Lewy-related alpha-synucleinopathy in olfactory mucosa. Neuropathology 33, 47–58.CrossRefGoogle ScholarPubMed

Gadoth, N., Mass, E., Gordon, C.R., Steiner, J.E., 1997. Taste and smell in familial dysautonomia. Developmental Medicine and Child Neurology 39, 393–397.Google ScholarPubMed

Galvin, J.E., Pollack, J., Morris, J.C., 2006. Clinical phenotype of Parkinson disease dementia. Neurology 67, 1605–1611.CrossRefGoogle ScholarPubMed

Gardiner, J., Barton, D., Vanslambrouck, J.M., et al. 2008. Defects in tongue papillae and taste sensation indicate a problem with neurotrophic support in various neurological diseases. Neuroscientist 14, 240–250.CrossRefGoogle ScholarPubMed

Garland, E.M., Raj, S.R., Peltier, A.C., Robertson, D., Biaggioni, I., 2011. A cross-sectional study contrasting olfactory function in autonomic disorders. Neurology 76, 456–460.CrossRefGoogle ScholarPubMed

Genter, M.B., Krishan, M., Preditor, R.D., 2015. The olfactory system as a route of delivery for agents to the brain and circulation. In: Doty, R.L. (Ed.), Handbook of Olfaction and Gustation. 3rd edition. Hoboken, NJ: John Wiley & Sons, pp. 453–484.CrossRefGoogle Scholar

Geser, F., Wenning, G.K., Poewe, W., McKeith, I., 2005. How to diagnose dementia with Lewy bodies: state of the art. Movement Disorders 20 Suppl 12, S11–20.CrossRefGoogle ScholarPubMed

Ghadami, M., Majidzadeh, A., Morovvati, S., et al. 2004. Isolated congenital anosmia with morphologically normal olfactory bulb in two Iranian families: A new clinical entity? American Journal of Medical Genetics Part A 127A, 307–309.CrossRefGoogle ScholarPubMed

Gilbert, P.E., Murphy, C., 2004. The effect of the ApoE epsilon4 allele on recognition memory for olfactory and visual stimuli in patients with pathologically confirmed Alzheimer’s disease, probable Alzheimer’s disease, and healthy elderly controls. Journal of Clinical Experimental Neuropsychology 26, 779–794.CrossRefGoogle ScholarPubMed

Gillner, M., Brittebo, E.B., Brandt, I., Soderkvist Appelgren, L-E., Gustafsson, J-A., 1987. Uptake and specific binding of 2 3 7 8-tetrachlorodibenzo-p-dioxin in the olfactory mucosa of mice and rats. Cancer Research 47, 4150–4159.Google ScholarPubMed

Glasl, L., Kloos, K., Giesert, F., et al. 2012. Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb. Experimental Neurology 235, 214–227.CrossRefGoogle ScholarPubMed

Glass, P.G., Lees, A.J., Mathias, C., Mason, L., Best, C., Williams, D.R., Katzenschlager, R., Silveira‐Moriyama, L., et al. 2011. Olfaction in pathologically proven patients with multiple system atrophy. Movement Disorders 27(2), 327–328.CrossRefGoogle ScholarPubMed

Goetz, C.G., Stebbins, G.T., Ouyang, B., 2011. Visual plus nonvisual hallucinations in Parkinson’s disease: Development and evolution over 10 years. Movement Disorders 26, 2196–2200.CrossRefGoogle ScholarPubMed

Goetz, C.G., Vogel, C., Tanner, C.M., Stebbins, G.T., 1998. Early dopaminergic drug-induced hallucinations in parkinsonian patients. Neurology 51, 811–814.CrossRefGoogle ScholarPubMed

Goker-Alpan, O., Lopez, G., Vithayathil, J., et al. 2008. The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. Archives of Neurology 65, 1353–1357.CrossRefGoogle ScholarPubMed

Goldstein, D.S., Sewell, L., 2009. Olfactory dysfunction in pure autonomic failure: Implications for the pathogenesis of Lewy body diseases. Parkinsonism & Related Disorders 15(7), 516–520.CrossRefGoogle ScholarPubMed

Goldstein, D.S., Holmes, C., Bentho, O., et al. 2008. Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy. Parkinsonism & Related Disorders 14, 600–607.CrossRefGoogle ScholarPubMed

Gottofrey, J., Tjalve, H., 1991. Axonal transport of cadmium in the olfactory nerve of the pike. Pharmacology & Toxicology 69, 242–252.CrossRefGoogle ScholarPubMed

Graves, A.B., Bowen, J.D., Rajaram, L., et al. 1999. Impaired olfaction as a marker for cognitive decline: Interaction with apolipoprotein E epsilon4 status. Neurology 53, 1480–1487.CrossRefGoogle ScholarPubMed

Gray, A.J., Staples, V., Murren, K., Dhariwal, A., Bentham, P., 2001. Olfactory identification is impaired in clinic-based patients with vascular dementia and senile dementia of Alzheimer type. International Journal of Geriatric Psychiatry 16(5), 513–517.CrossRefGoogle ScholarPubMed

Gray, J.M., Young, A.W., Barker, W.A., Curtis, A., Gibson, D., 1997. Impaired recognition of disgust in Huntington’s disease gene carriers. Brain 120(Pt 11), 2029–2038.CrossRefGoogle ScholarPubMed

Gresham, L.S., Molgaard, C.A., Smith, R.A., 1993. Induction of cytochrome P-450 enzymes via tobacco smoke: A potential mechanism for developing resistance to environmental toxins as related to parkinsonism and other neurologic diseases. Neuroepidemiology 12(2), 114–116.CrossRefGoogle Scholar

Haehner, A., Hummel, T., Hummel, C., et al. 2007. Olfactory loss may be a first sign of idiopathic Parkinson’s disease. Movement Disorders 22, 839–842.CrossRefGoogle ScholarPubMed

Hague, K., Lento, P., Morgello, S., Caro, S., Kaufmann, H., 1997. The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature. Acta Neuropathol 94, 192–196.CrossRefGoogle ScholarPubMed

Halliday, G., Del Tredici, K., Braak, H., 2006. Critical appraisal of the Braak staging of brain pathology related to sporadic Parkinson’s disease. Journal of Neural Transmission Suppl 70, 99–103.Google Scholar

Halliday, G.M., Barker, R.A., Rowe, D.B., 2011. Non-dopamine Lesions in Parkinson’s Disease. Oxford: Oxford University Press.Google Scholar

Hamilton, J.M., Murphy, C., Paulsen, J.S., 1999. Odour detection learning and memory in Huntington’s disease. Journal of the International Neuropsychological Society 5, 609–615.CrossRefGoogle ScholarPubMed

Hamir, A.N., Kunkle, R.A., Richt, J.A., Miller, J.M., Greenlee, J.J., 2008. Experimental transmission of US scrapie agent by nasal, peritoneal, and conjunctival routes to genetically susceptible sheep. Veterinary Pathology 45, 7–11.CrossRefGoogle ScholarPubMed

Handley, O.J., Morrison, C.M., Miles, C., Bayer, A.J., 2006. ApoE gene and familial risk of Alzheimer’s disease as predictors of odour identification in older adults. Neurobiology of Aging 27, 1425–1430.CrossRefGoogle ScholarPubMed

Hardy, J., 2005. Expression of normal sequence pathogenic proteins for neurodegenerative disease contributes to disease risk: “Permissive templating” as a general mechanism underlying neurodegeneration. Biochemical Society Transactions 33, 578–581.CrossRefGoogle ScholarPubMed

Hawkes, C.H., Shephard, B.C., 1992. Olfactory impairment in Parkinson’s disease: Evidence of dysfunction measured by olfactory event-related potentials and smell identification tests. Annals of Neurology 32, 248 (abstract).Google Scholar

Hawkes, C.H., Shephard, B.C., 1993, Selective anosmia in Parkinson’s disease? Lancet Neurology 341, 435–436.CrossRefGoogle ScholarPubMed

Hawkes, C.H., Shephard, B.C., 1998. Olfactory evoked responses and identification tests in neurological disease. Annals of New York Academy of Science 855, 608–615.CrossRefGoogle ScholarPubMed

Hawkes, C., Shah, M., Fogo, A., 2005. Smell identification declines from age 36 years and mainly affects pleasant odours. Movement Disorders 20 (Suppl. 10) S48. P160 (abstract).Google Scholar

Hawkes, C.H., Del Tredici, K, Braak, H., 2007. Parkinson’s disease: A dual-hit hypothesis. Neuropathology and Applied Neurobiology 33(6), 599–614.CrossRefGoogle ScholarPubMed

Hawkes, C.H., 2008a. Parkinson’s disease and aging: same or different process? Movement Disorders 23(1), 47–53.CrossRefGoogle ScholarPubMed

Hawkes, C.H., 2008b. The prodromal phase of sporadic Parkinson’s disease: Does it exist and if so how long is it? Movement Disorders 23, 1799–1807.CrossRefGoogle Scholar

Hawkes, C.H., Del Tredici, K., Braak, H., 2010. A timeline for Parkinson’s disease. Parkinsonism & Related Disorders 16, 79–84.CrossRefGoogle ScholarPubMed

Hawkes, C.H., Shephard, B.C., Daniel, SE. (1997). Olfactory dysfunction in Parkinson’s disease. Journal of Neurology, Neurosurgery, & Psychiatry 62, 436–436.CrossRefGoogle ScholarPubMed

Hayes, C.J., Stevenson, R.J., Coltheart, M., 2007. Disgust and Huntington’s disease. Neuropsychologia 45, 1135–1151.CrossRefGoogle ScholarPubMed

Hemdal, P., Corwin, J., Oster, H., 1993. Olfactory identification deficits in Down’s syndrome and idiopathic mental retardation. Neuropsychologia 31, 977–984.CrossRefGoogle ScholarPubMed

Hensiek, A.E., Bhatia, K., Hawkes, C.H., 2000. Olfactory function in drug induced parkinsonism. Journal of Neurology 247(3), 303.Google Scholar

Hentschel, K., Baba, Y., Williams, L.N., et al. 2005. Olfaction in familial parkinsonism (FP). Movement Disorders 20, P175, S52–S52.Google Scholar

Hext, P.M., Lock, E.A., 1992. The accumulation and metabolism of 3-trifluoromethylpyridine by rat olfactory and hepatic tissues. Toxicology 72, 61–75.CrossRefGoogle ScholarPubMed

Höglinger, G.U., Alvarez-Fischer, D., Arias-Carrión, O., et al. 2015. A new dopaminergic nigro-olfactory projection. Acta neuropathologica 130(3), 333–348.CrossRefGoogle ScholarPubMed

Holter, S.M., Stromberg, M., Kovalenko, M., et al. 2013. A broad phenotypic screen identifies novel phenotypes driven by a single mutant allele in Huntington’s disease CAG knock-in mice. PLoS One 8, e80923.CrossRefGoogle ScholarPubMed

Hozumi, S., Nakagawasai, O., Tan-No, K., Niijima, F., Yamadera, F., Murata, A., Arai, Y., Yasuhara, H., Tadano, T., 2003. Characteristics of changes in cholinergic function and impairment of learning and memory-related behavior induced by olfactory bulbectomy. Behavioural Brain Research 138(1), 9–15.CrossRefGoogle ScholarPubMed

Huart, C., Rombaux, P., Gérard, T., Hanseeuw, B., Lhommel, R., Quenon, L., Ivanoiu, A., Mouraux, A., 2015. Unirhinal olfactory testing for the diagnostic workup of mild cognitive impairment. Journal of Alzheimer’s Disease 47(1), 253–270.CrossRefGoogle ScholarPubMed

Hughes, A.J., Daniel, S.E., Lees, A.J. 2001. Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease. Neurology 57(8), 1497–1499.CrossRefGoogle ScholarPubMed

Huisman, E., Uylings, H.B, Hoogland, P.V., 2004. A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson’s disease. Movement Disorders 19, 687–692.CrossRefGoogle ScholarPubMed

Huisman, E., Uylings, HB., Hoogland, PV., 2008. Gender-related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson’s disease patients. Movement Disorders 23, 1407–1413.CrossRefGoogle ScholarPubMed

Iijima, M., Osawa, M., Momose, M., et al. 2010. Cardiac sympathetic degeneration correlates with olfactory function in Parkinson’s disease. Movement Disorders 25(9), 1143–1149.CrossRefGoogle ScholarPubMed

Imamura, K., Matumoto, S., Mabuchi, N., et al. 2009. Relationship between the regional cerebral blood flow and the cognitive function and anosmia in patients with Parkinson disease and Alzheimer disease. Brain Nerve 61(6), 683–690.Google ScholarPubMed

Iranzo, A., Molinuevo, J.L., Santamaria, J., et al. 2006. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: A descriptive study. Lancet Neurology 5, 572–577.CrossRefGoogle ScholarPubMed

Iscan, M., Reuhl, K., Weiss, B., Maines, M.D., 1990. Regional and subcellular distribution of cytochrome P-450-dependent drug metabolism in monkey brain: The olfactory bulb and the mitrochondrial fraction have high levels of activity. Biochemical and Biophysical Research Communications 169, 858–863.CrossRefGoogle Scholar

Jellinger, K.A. 2009. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathologica 117(2), 215–6CrossRefGoogle ScholarPubMed

Jennings, D., Siderowf, A., Stern, M., et al. 2014. Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study. Neurology 83, 1739–1746.CrossRefGoogle ScholarPubMed

Johansen, K.K., White, L.R., Farrer, M.J., Aasly, J.O., 2011. Subclinical signs in LRRK2 mutation carriers. Parkinsonism & Related Disorders 17, 528–532.CrossRefGoogle ScholarPubMed

Juncos, J.L., Lazarus, J.T., Rohr, J., et al. 2012. Olfactory dysfunction in fragile X tremor ataxia syndrome. Movement Disorders 27, 1556–1559.CrossRefGoogle ScholarPubMed

Kalaitzakis, M.E., Graeber, M.B., Gentleman, S.M., Pearce, R.K., 2008. The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson’s disease: A critical analysis of alpha-synuclein staging. Neuropathology and Applied Neurobiology 34, 284–295.CrossRefGoogle Scholar

Kalmey, J.K., Thewissen, J.G., Dluzen, DE. 1998. Age-related size reduction of foramina in the cribriform plate. Anatomical Record 251(3), 326–329.3.0.CO;2-T>CrossRefGoogle ScholarPubMed

Kandasamy, M., Rosskopf, M., Wagner, K., et al. 2015. Reduction in subventricular zone-derived olfactory bulb neurogenesis in a rat model of Huntington’s disease is accompanied by striatal invasion of neuroblasts. PLoS One 10, e0116069.CrossRefGoogle Scholar

Kashihara, K., Hanaoka, A., Imamura, T., 2011. Frequency and characteristics of taste impairment in patients with Parkinson’s disease: Results of a clinical interview. Internal Medicine 50(20), 2311–2315.CrossRefGoogle ScholarPubMed

Kareken, D.A., Doty, R.L., Moberg, P.J., et al. 2001. Olfactory-evoked regional cerebral blood flow in Alzheimer’s disease. Neuropsychology 15(1), 18–29.CrossRefGoogle ScholarPubMed

Katzman, R., 1986. Alzheimer’s disease. New England Journal of Medicine 314, 964–973.CrossRefGoogle ScholarPubMed

Katzman, R., 1986. Differential diagnosis of dementing illnesses. Neurologic Clinics 4, 329–340.CrossRefGoogle ScholarPubMed

Kaufmann, H., Nahm, K., Purohit, D., Wolfe, D., 2004. Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology 63, 1093–1095.CrossRefGoogle ScholarPubMed

Kertelge, L., Bruggemann, N., Schmidt, A., et al. 2010. Impaired sense of smell and color discrimination in monogenic and idiopathic Parkinson’s disease. Movement Disorders 25, 2665–2669.CrossRefGoogle ScholarPubMed

Khan, N.L., Katzenschlager, R., Watt, H., et al. 2004. Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease. Neurology 62, 1224–1226.CrossRefGoogle ScholarPubMed

Killgore, W.D.S., McBride, S.H., 2006. Odour identification accuracy declines following 24 h of sleep deprivation. J Sleep Res 15, 111–116.CrossRefGoogle Scholar

Kim, H.J., Jeon, B.S., Lee, J.Y., et al. 2011. Taste function in patients with Parkinson disease. Journal of Neurology 258, 1076–1079.CrossRefGoogle ScholarPubMed

Kishikawa, M., Iseki, M., Sakae, M., Kawaguchi, S., Fujii, H., 1994. Early diagnosis of Alzheimer’s? Nature 369(6479), 365–366.CrossRefGoogle ScholarPubMed

Klein, C., Schneider, S.A., Lang, A.E., 2009. Hereditary parkinsonism: Parkinson disease look-alikes–an algorithm for clinicians to “PARK” genes and beyond. Movement Disorders 24(14), 2042–2058.CrossRefGoogle ScholarPubMed

Klimek, L., 1998. Sense of smell in allergic rhinitis. Pneumologie 52, 196–202.Google ScholarPubMed

Knupfer, L., Spiegel, R., 1986. Differences in olfactory test performance between normal aged, Alzheimer and vascular type dementia individuals. International Journal of Geriatric Psychiatry 1(1), 3–14.CrossRefGoogle Scholar

Kobal, G., Plattig, K.H., 1978. [Objective olfactometry: Methodological annotations for recording olfactory EEG-responses from the awake human]. EEG EMG Z eitschrift Fur Elektroenzephalographie, Elektromyographie Und Verwandte Gebiete 9, 135–145.Google ScholarPubMed

Koss, E., Weiffenbach, J.M., Haxby, J.V., Friedland, R.P., 1988. Olfactory detection and identification performance are dissociated in early Alzheimer’s disease. Neurology 38(8), 1228–1228.CrossRefGoogle ScholarPubMed

Kovacs, T., Papp, M.I., Cairns, N.J., Khan, M.N., Lantos, P.L. 2003. Olfactory bulb in multiple system atrophy. Movement Disorders 18, 938–942.CrossRefGoogle ScholarPubMed

Kovacs, G.G., Trabattoni, G., Hainfellner, J.A., et al. 2002. Mutations of the prion protein gene phenotypic spectrum. Journal of Neurology 249, 1567–1582.Google ScholarPubMed

Kovács, T., 2013. The olfactory system in Alzheimer’s disease: Pathology, pathophysiology and pathway for therapy. Translational Neuroscience 4(1), 34–45.CrossRefGoogle Scholar

Kovacs, T., Cairns, N.J., Lantos, P.L., 2001. Olfactory centres in Alzheimer’s disease: Olfactory bulb is involved in early Braak’s stages. Neuroreport 12, 285–288.CrossRefGoogle ScholarPubMed

Krismer, F., Wenning, G.K., Li, Y., Poewe, W., Stefanova, N. 2013. Intact olfaction in a mouse model of multiple system atrophy. PLoS One, 8, e64625.CrossRefGoogle Scholar

Krüger, R., Müller, T., Riess, O., 2000. Involvement of α-synuclein in Parkinson’s disease and other neurodegenerative disorders. Journal of Neural Transmission 107(1), 31–40.Google ScholarPubMed

Krüger, S., Haehner, A., Thiem, C., Hummel, T. 2008. Neuroleptic-induced parkinsonism is associated with olfactory dysfunction. Journal of Neurology 255(10), 1574–1579.CrossRefGoogle ScholarPubMed

Kumar, K.R., Weissbach, A., Heldmann, M., et al. 2012. Frequency of the D620 N mutation in VPS35 in Parkinson disease. Archives of Neurology 69, 1360–1364.CrossRefGoogle Scholar

Kurtenbach, S., Wewering, S., Hatt, H., Neuhaus, E.M., Lubbert, H. 2013., Olfaction in three genetic and two MPTP-induced Parkinson’s disease mouse models. PLoS One 8, e77509.CrossRefGoogle ScholarPubMed

Landis, B.N., Burkhard, P.R., 2008. Phantosmias and Parkinson disease. Archives of Neurology 65, 1237–1239.CrossRefGoogle ScholarPubMed

Lang, C.J., Leuschner, T., Ulrich, K. et al. 2006. Taste in dementing diseases and parkinsonism. Journal of the Neurological Sciences 248, 177–184.CrossRefGoogle ScholarPubMed

Lang, C., Schwandner, K., Hecht, M., 2011. Do patients with motor neuron disease suffer from disorders of taste or smell? Amyotrophic Lateral Sclerosis 12, 368–371.CrossRefGoogle ScholarPubMed

Larson, J., Kim, D., Patel, R.C., Floreani, C., 2008. Olfactory discrimination learning in mice lacking the fragile X mental retardation protein. Neurobiology of Learning and Memory 90, 90–102.CrossRefGoogle ScholarPubMed

Le Pichon, C.E., Valley, M.T., Polymenidou, M., et al. 2009. Olfactory behavior and physiology are disrupted in prion protein knockout mice. Nature Neuroscience 12, 60–69.CrossRefGoogle ScholarPubMed

Lee, D.H., Oh, J.S., Ham, J.H., et al. 2015. Is normosmic Parkinson disease a unique clinical phenotype? Neurology 85(15), 1270–1275.CrossRefGoogle ScholarPubMed

Lee, L.V., Munoz, E.L., Tan, K.T., Reyes, M.T., 2001. Sex linked recessive dystonia parkinsonism of Panay, Philippines (XDP). Molecular Pathology 54, 362–368.Google ScholarPubMed

Lee, P.H., Yeo, S.H., Yong, S.W., Kim, Y.J., 2007. Odour identification test and its relation to cardiac 123I-metaiodobenzylguanidine in patients with drug induced parkinsonism. Journal of Neurology, Neurosurgery, & Psychiatry 78, 1250–1252.CrossRefGoogle ScholarPubMed

Lehman, C.D., Bartoshuk, L.M., Catalanotto, F.C., Kveton, J.F., Lowlicht, R.A., 1995. Effect of anesthesia of the chorda tympani nerve on taste perception in humans. Physiology & Behavior 57(5), 943–51.CrossRefGoogle ScholarPubMed

Lelan, F., Boyer, C., Thinard, R., et al. 2011. Effects of Human Alpha-Synuclein A53T-A30P Mutations on SVZ and Local Olfactory Bulb Cell Proliferation in a Transgenic Rat Model of Parkinson Disease. Journal of Parkinson’s Disease 987084.Google Scholar

Lesage, S., Anheim, M., Condroyer, C., et al 1995. French Parkinson’s Disease Genetics Study Group. Large-scale screening of the Gaucher’s disease-related glucocerebrosidase gene in Europeans with Parkinson’s disease. Human Molecular Genetics 2011; 20(1), 202–10.Google Scholar

Lesage, S., Durr, A., Brice, A., 2007. LRRK2: A link between familial and sporadic Parkinson’s disease? Pathologie Biologie (Paris), 55, 107–110.CrossRefGoogle ScholarPubMed

Li, A.A., Mink, P.J., McIntosh, L.J., Teta, M.J., Finley, B., 2005. Evaluation of epidemiologic and animal data associating pesticides with Parkinson’s disease. Occupational and Environmental Medicine 47(10), 1059–1087.CrossRefGoogle ScholarPubMed

Liberini, P., Parola, S., Spano, P.F., Antonini, L., 2000. Olfaction in Parkinson’s disease: Methods of assessment and clinical relevance. Journal of Neurology 247, 88–96CrossRefGoogle ScholarPubMed

Liou, H.H., Tsai, M.C., Chen, C.J., et al. 1997. Environmental risk factors and Parkinson’s disease: a case-control study in Taiwan. Neurology 48(6), 1583–1588.CrossRefGoogle ScholarPubMed

Lohmann, E., Leclere, L., De Anna, F., et al. 2009. French Parkinson’s Disease Genetics Study Group. A clinical, neuropsychological and olfactory evaluation of a large family with LRRK2 mutations. Parkinsonism & Related Disorders 15(4), 273–276.CrossRefGoogle Scholar

Louis, E.D., Bromley, S.M., Jurewicz, E.C., Watner, D., 2002. Olfactory dysfunction in essential tremor: A deficit unrelated to disease duration or severity. Neurology, 59(10), 1631–1633.CrossRefGoogle ScholarPubMed

Louis, E.D., Jurewicz, E.C., 2003. Olfaction in essential tremor patients with and without isolated rest tremor. Movement Disorders 18(11), 1387–1389.CrossRefGoogle ScholarPubMed

Louis, E.D., Rios, E., Pellegrino, K.M., et al. 2008. Higher blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations correlate with lower olfactory scores in essential tremor. Neurotoxicology 29, 460–465.CrossRefGoogle ScholarPubMed

Louis, E.D., Vonsattel, J.P., Honig, L.S., et al. 2006. Neuropathologic findings in essential tremor. Neurology 66(11), 1756–1759.CrossRefGoogle ScholarPubMed

Louis, E.D., Faust, P.L., Ma, K.J., et al. 2011. Torpedoes in the Cerebellar Vermis in Essential Tremor Cases vs. Controls. Cerebellum 10, 812–819.CrossRefGoogle ScholarPubMed

Lovell, M.A., Jafek, B.W., Moran, D.T., Rowley, J.C., 1982. Biopsy of human olfactory mucosa: An instrument and a technique. Archives of Otolaryngology 247–249.CrossRefGoogle Scholar

Lucassen, E.B., Sterling, N.W., Lee, E.Y., et al. 2014. History of smoking and olfaction in Parkinson’s disease. Movement Disorders 29(8), 1069–1074.CrossRefGoogle ScholarPubMed

Luzzi, S., Snowden, J.S., Neary, D., Coccia, M., Provinciali, L., Lambon Ralph, M.A., 2007. Distinct patterns of olfactory impairment in Alzheimer’s disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration. Neuropsychologia 45(8), 1823–1831.CrossRefGoogle ScholarPubMed

Macknin, J.B., Higuchi, M., Lee, V.M.Y., Trojanowski, J.Q., Doty, R.L., 2004. Olfactory dysfunction occurs in transgenic mice overexpressing human τ protein. Brain Research 1000(1), 174–178.CrossRefGoogle ScholarPubMed

Magerova, H., Vyhnalek, M., Laczo, J., et al. 2014. Odor Identification in Frontotemporal Lobar Degeneration Subtypes. American Journal of Alzheimer’s Disease and Other Dementias.CrossRefGoogle Scholar

Mann, D.M., 1988. Alzheimer’s disease and Down’s syndrome. Histopathology 13, 125–137.CrossRefGoogle ScholarPubMed

Mann, D.M., 1989. The pathogenesis and progression of the pathological changes of Alzheimer’s disease. Annals of Medicine 21(2), 133–136.CrossRefGoogle ScholarPubMed

Markesbery, W.R., Jicha, G.A., Liu, H., Schmitt, FA. 2009. Lewy body pathology in normal elderly subjects. Journal of Neuropathology and Experimental Neurology 68, 816–822.CrossRefGoogle ScholarPubMed

Markopoulou, K., Larsen, K.W., Wszolek, E.K., et al. 1997. Olfactory dysfunction in familial parkinsonism. Neurology 49, 1262–1267.CrossRefGoogle ScholarPubMed

Marras, C., Goldman, S., Smith, A., et al. 2005. Smell identification ability in twin pairs discordant for Parkinson’s disease. Movement Disorders 20(6), 687–693.CrossRefGoogle ScholarPubMed

Martel, G., Simon, A., Nocera, S., et al. 2015. Aging, but not tau pathology, impacts olfactory performances and somatostatin systems in THY-Tau22 mice. Neurobiology of Aging 36(2), 1013–1028.CrossRefGoogle Scholar

Masucci, MG. 2004.Epstein-Barr virus oncogenesis and the ubiquitin-proteasome system. Oncogene 23, 2107–2115.CrossRefGoogle ScholarPubMed

McAuley, J.H., Gregory, S., 2012. Prevalence and clinical course of olfactory hallucinations in idiopathic Parkinson’s disease. Journal of Parkinson’s Disease 2, 199–205.CrossRefGoogle ScholarPubMed

McKeith, I.G., 2006. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop. Journal of Alzheimer’s Disease 9 (3 Suppl), 417–423.CrossRefGoogle Scholar

McKeown, D.A., Doty, R.L., Perl, D.P., Frye, R.E., Simms, I., Mester, A., 1996. Olfactory function in young adolescents with Down’s syndrome. Journal of Neurology, Neurosurgery, & Psychiatry 61, 412–414.CrossRefGoogle ScholarPubMed

McLaughlin, N.C., Westervelt, H.J., 2008. Odor identification deficits in frontotemporal dementia: a preliminary study. Archives of Clinical Neuropsychology 23(1), 119–123.CrossRefGoogle ScholarPubMed

McNeill, A., Duran, R., Proukakis, C., et al. 2012. Hyposmia and cognitive impairment in Gaucher disease patients and carriers. Movement Disorders 27, 526–532.CrossRefGoogle ScholarPubMed

McShane, R.H., Nagy, Z., Esiri, M.M., et al. 2001. Anosmia in dementia is associated with Lewy bodies rather than Alzheimer’s pathology. Journal of Neurology, Neurosurgery, & Psychiatry 70, 739–743.CrossRefGoogle ScholarPubMed

Mesholam, R.I., Moberg, P.J., Mahr, R.N., Doty, R.L., 1998. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer’s and Parkinson’s diseases. Archives of Neurology 55, 84–90.CrossRefGoogle ScholarPubMed

Meusel, T., Westermann, B., Fuhr, P., Hummel, T., Welge-Lussen, A., 2010. The course of olfactory deficits in patients with Parkinson’s disease–a study based on psychophysical and electrophysiological measures. Neuroscience Letters 486, 166–170.CrossRefGoogle ScholarPubMed

Mirelman, A., Alcalay, R.N., Saunders-Pullman, R., et al. 2015. Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene. Movement Disorders 30, 981–986.CrossRefGoogle ScholarPubMed

Mitchell, I.J., Heims, H., Neville, E.A., Rickards, H., 2005. Huntington’s disease patients show impaired perception of disgust in the gustatory and olfactory modalities. The Journal of Neuropsychiatry and Clinical Neurosciences 17, 119–121.CrossRefGoogle ScholarPubMed

Miwa, T., Watanabe, A., Mitsumoto, Y., et al. 2004. Olfactory impairment and Parkinson’s disease-like symptoms observed in the common marmoset following administration of 1-methyl-4-phenyl-1 2 3 6-tetrahydropyridine. Acta Otolaryngologica Suppl. (553): 80–84.CrossRefGoogle Scholar

Moberg, P.J., Doty, R.L., 1997. Olfactory function in Huntington’s disease patients and at-risk offspring. International Journal of Neuroscience; 89, 133–139.CrossRefGoogle ScholarPubMed

Moberg, P.J., McGue, C., Kanes, S.J., et al. 2007. Phenylthiocarbamide (PTC) perception in patients with schizophrenia and first-degree family members: Relationship to clinical symptomatology and psychophysical olfactory performance. Schizophrenia Research 90(1–3), 221–228.CrossRefGoogle ScholarPubMed

Moberg, P.J., Pearlson, G.D., Speedie, L.J., et al. 1987. Olfactory recognition: differential impairments in early and late Huntington’s and Alzheimer’s disease. Journal of Clinical Experimental Neuropsychology 9, 650–664.CrossRefGoogle Scholar

Moccia, M., Picillo, M., Erro, R., et al. 2014. How does smoking affect olfaction in Parkinson’s disease? Journal of the Neurological Sciences 340(1), 215–217.CrossRefGoogle ScholarPubMed

Montgomery, E.B. Jr, Baker, K.B., Lyons, K., Koller, W.C., (1999) Abnormal performance on the PD test battery by asymptomatic first-degree relatives. Neurology 52, 757–762.CrossRefGoogle ScholarPubMed

Montgomery, E.B. Jr., Koller, W.C., LaMantia, T.J., et al. (2000) Early detection of probable idiopathic Parkinson’s disease: I. Development of a diagnostic test battery. Movement Disorders, 15, 467–473.3.0.CO;2-#>CrossRefGoogle ScholarPubMed

Morgan, C.D., Murphy, C., 2002. Olfactory event-related potentials in Alzheimer’s disease. Journal of the International Neuropsychological Society 8, 753–763.CrossRefGoogle ScholarPubMed

Morley, J.F., Pawlowski, S.M., Kesari, A., et al. 2014. Motor and non-motor features of Parkinson’s disease that predict persistent drug-induced Parkinsonism. Parkinsonism & Related Disorders 20, 738–742.CrossRefGoogle ScholarPubMed

Moscovich, M., Munhoz, R.P., Teive, H.A., et al. 2012. Olfactory impairment in familial ataxias. Journal of Neurology, Neurosurgery, & Psychiatry 83, 970–974.CrossRefGoogle ScholarPubMed

Mueller, A., Reuner, U., Landis, B. et al. 2006. Extrapyramidal symptoms in Wilson’s disease are associated with olfactory dysfunction. Movement Disorders 21, 1311–1316.CrossRefGoogle ScholarPubMed

Muller, A., Mungersdorf, M., Reichmann, H., Strehle, G., Hummel, T., 2002. Olfactory function in Parkinsonian syndromes. Journal of Clinical Neuroscience 9, 521–524.CrossRefGoogle ScholarPubMed

Mundiñano, I.C., Hernandez, M., Dicaudo, C., et al. 2013, Reduced cholinergic olfactory centrifugal inputs in patients with neurodegenerative disorders and MPTP-treated monkeys. Acta Neuropathologica 126, 411–425.CrossRefGoogle ScholarPubMed

Mundinano, I.C., Caballero, M.C., Ordonez, C., et al. 2011. Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders. Acta Neuropathologica 122, 61–74.CrossRefGoogle ScholarPubMed

Murphy, C., Gilmore, M.M., Seery, C.S., Salmon, D.P., Lasker, BR. (1990). Olfactory thresholds are associated with degree of dementia in Alzheimer’s disease. Neurobiology of Aging 11, 465–469.CrossRefGoogle ScholarPubMed

Murphy, C., Jinich, S., 1996. Olfactory dysfunction in Down’s Syndrome. Neurobio Aging, 17, 631–637.CrossRefGoogle ScholarPubMed

Murphy, C., Schubert, C.R., Cruickshanks, K.J., Klein, B.E., Klein, R., Nondahl, D.M., 2002. Prevalence of olfactory impairment in older adults. Jama, 288(18), 2307–2312.CrossRefGoogle ScholarPubMed

Najim al-Din, A.S., Wriekat, A., Mubaidin, A., Dasouki, M., Hiari, M., 1994. Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome. Acta Neurologica Scandinavica 89, 347–52.Google ScholarPubMed

Navarro-Otano, J., Gaig, C., Muxi, A., et al. 2014. 123I-MIBG cardiac uptake, smell identification and 123I-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson’s disease. Parkinsonism & Related Disorders 20, 192–197.CrossRefGoogle ScholarPubMed

Nee, L.E., Scott, J., Polinsky, R.J., 1993. Olfactory dysfunction in the Shy-Drager syndrome. Clinical Autonomic Research 3, 281–282.CrossRefGoogle ScholarPubMed

Nee, L.E., Lippa, C.F., 2001, Inherited Alzheimer’s disease PS-1 olfactory function: A 10-year follow-up study. American Journal of Alzheimer’s Disease & Other Dementias, 16, 83–84.CrossRefGoogle ScholarPubMed

Neudorfer, O., Giladi, N., Elstein, D., et al. 1996. Occurrence of Parkinson’s syndrome in type I Gaucher disease. QJM 89, 691–694.CrossRefGoogle ScholarPubMed

Neumann, J., Bras, J., Deas, E., et al. 2009. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson’s disease. Brain 132, 1783–1794.CrossRefGoogle ScholarPubMed

Newman, R., Winans, S.S., 1980. An experimental study of the ventral striatum of the golden hamster. II Neuronal connections of the olfactory tubercle. Journal of Comparative Neurology 191, 193–212.CrossRefGoogle ScholarPubMed

Nijjar, R.K., Murphy, C., 2002. Olfactory impairment increases as a function of age in persons with Down syndrome. Neurobiology of Aging 23(1), 65–73.CrossRefGoogle ScholarPubMed

Nishioka, K., Ross, O.A., Ishii, K., et al. 2009. Expanding the clinical phenotype of SNCA duplication carriers. Movement Disorders 24, 1811–1819.CrossRefGoogle ScholarPubMed

Nordin, S., Almkvist, O., Berglund, B., Wahlund, L.O., 1997. Olfactory dysfunction for pyridine and dementia progression in Alzheimer disease. Archives of Neurology 54, 993–998.CrossRefGoogle ScholarPubMed

Nordin, S., Paulsen, J.S., Murphy, C., 1995b. Sensory- and memory-mediated olfactory dysfunction in Huntington’s disease. Journal of the International Neuropsychological Society 1, 281–290.CrossRefGoogle ScholarPubMed

Nores, J.M., Biacabe, B., Bonfils, P., 2000. [Olfactory disorders due to medications: analysis and review of the literature]. De Medecine Interne 21, 972–977.Google ScholarPubMed

Nosrat, C.A., 1998. Neurotrophic factors in the tongue: expression patterns, biological activity, relation to innervation and studies of neurotrophin knockout mice. Annals of the New York Academy of Sciences 855, 28–49.CrossRefGoogle ScholarPubMed

Noyce, A.J., Bestwick, J.P., Silveira-Moriyama, L., et al. 2014. PREDICT-PD: Identifying risk of Parkinson’s disease in the community: Methods and baseline results. Journal of Neurology, Neurosurgery, & Psychiatry 85, 31–37.CrossRefGoogle ScholarPubMed

Noyce, A.J., Mencacci, N.E., Schrag, A., et al. 2015. Web-based assessment of Parkinson’s prodromal markers identifies GBA variants. Movement Disorders 30, 1002–1003.CrossRefGoogle ScholarPubMed

Noyce, A.J., R’Bibo, L., Peress, L., Bestwick, J.P., Adams‐Carr, K.L., Mencacci, N.E., Hawkes, C.H., Masters, J.M., Wood, N., Hardy, J., Giovannoni, G., 2017. PREDICT‐PD: An online approach to prospectively identify risk indicators of Parkinson’s disease. Movement Disorders 32(2), 219–226.CrossRefGoogle ScholarPubMed

Oakley, B., Witt, M., 2004. Building sensory receptors on the tongue. Journal of Neurocytology 33, 631–646.CrossRefGoogle ScholarPubMed

Okamoto, K., Hirai, S., Shoji, M., Takatama, M. 1990. Senile changes in the human olfactory bulbs. In Nagatsu, T (Ed), Basic, Clinical, and Therapeutic Aspects of Alzheimer’s and Parkinson’s Diseases. NY: Plenum Press, pp. 349–352.CrossRefGoogle Scholar

Oleson, S., Murphy, C., 2015. Olfactory Dysfunction in ApoE ɛ4/4 Homozygotes with Alzheimer’s Disease. Journal of Alzheimer’s Disease 46(3), 791–803.CrossRefGoogle ScholarPubMed

Olichney, J.M., Murphy, C., Hofstetter, C.R., et al. 2005. Anosmia is very common in the Lewy body variant of Alzheimer’s disease. JM 76, 1342–1347.Google ScholarPubMed

Oliver, C., Holland, A.J., 1986. Down’s syndrome and Alzheimer’s disease: a review. Psychological Medicine 16, 307–322.CrossRefGoogle ScholarPubMed

Omar, R., Mahoney, C.J., Buskley, A.H., Warren, J.D. 2013. Flavour identification in frontotemporal lobar degeneration. Journal of Neurology, Neurosurgery, & Psychiatry 84(1), 88–93.CrossRefGoogle ScholarPubMed

Ondo, W.G., Lai, D., 2005. Olfaction testing in patients with tremor-dominant PD: Is this a distinct condition? Movement Disorders 20: 471–475.CrossRefGoogle Scholar

Oyanagi, K., The nature of the parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam and magnesium deficiency. Parkinsonism & Related Disorders 11 Suppl 1: S17–23.CrossRefGoogle Scholar

Paisan-Ruiz, C., Li, A., Schneider, S.A., Holton, J.L., Johnson, R., Kidd, D., Chataway, J., Bhatia, K.P., Lees, A.J., Hardy, J, Revesz, T., 2010. Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiology of Aging 33(4), 814–823.CrossRefGoogle ScholarPubMed

Papaioannou, N., Tooten, P.C., van Ederen, A.M., et al. 2001. Immunohistochemical investigation of the brain of aged dogs. I. Detection of neurofibrillary tangles and of 4-hydroxynonenal protein, an oxidative damage product, in senile plaques. Amyloid 8(1), 11–21.CrossRefGoogle ScholarPubMed

Pardini, M., Huey, E.D., Cavanagh, A.L., Grafman, J., 2009. Olfactory function in corticobasal syndrome and frontotemporal dementia. Archives of Neurology 66, 92–96.CrossRefGoogle ScholarPubMed

Park, J.S., Blair, N.F., Sue, C.M., 2015. The role of ATP13A2 in Parkinson’s disease: Clinical phenotypes and molecular mechanisms. Movement Disorders 30, 770–779.CrossRefGoogle ScholarPubMed

Parkkinen, L., Kauppinen, T., Pirttilä, T., Autere, J.M., Alafuzoff, I. 2005. Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia. Annals of Neurology 57, 82–91.CrossRefGoogle ScholarPubMed

Paschen, L., Schmidt, N., Wolff, S., et al. 2015. The olfactory bulb volume in patients with idiopathic Parkinson’s disease. European Journal of Neurology 22, 1068–1073.CrossRefGoogle ScholarPubMed

Paulsen, J.S., Langbehn, D.R., Stout, J.C., et al. 2008. Detection of Huntington’s disease decades before diagnosis: the Predict-HD study. Journal of Neurology, Neurosurgery, & Psychiatry 79, 874–880.CrossRefGoogle ScholarPubMed

Pearce, R.K., Hawkes, C.H., Daniel, S.E., 1995. The anterior olfactory nucleus in Parkinson’s disease. Movement Disorders 10, 283–287.CrossRefGoogle ScholarPubMed

Petzold, G.C., Einhaupl, K.M., Valdueza, J.M., 2003. Persistent bitter taste as an initial symptom of amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, & Psychiatry 74, 687–688.CrossRefGoogle ScholarPubMed

Pirogovsky, E., Gilbert, P.E., Jacobson, M., et al. 2007. Impairments in source memory for olfactory and visual stimuli in preclinical and clinical stages of Huntington’s disease. Journal of Clinical Experimental Neuropsychology 29, 395–404.CrossRefGoogle ScholarPubMed

Pittock, S.J., Joyce, C., O’Keane, V., et al. 2000. Rapid-onset dystonia-parkinsonism: A clinical and genetic analysis of a new kindred. Neurology 55, 991–995.CrossRefGoogle ScholarPubMed

Piwnica-Worms, K.E., Omar, R., Hailstone, J.C., Warren, J.D., 2010. Flavour processing in semantic dementia. Cortex 46, 761–768.CrossRefGoogle ScholarPubMed

Poddighe, S., Bhat, K.M., Setzu, M.D., et al. 2013. Impaired sense of smell in a Drosophila Parkinson’s model. PLoS One 8, e73156.CrossRefGoogle Scholar

Politis, M., Wu, K., Molloy, S., et al. 2010. Parkinson’s disease symptoms: The patient’s perspective. Movement Disorders 25, 1646–1651.CrossRefGoogle ScholarPubMed

Ponsen, M.M., Stoffers, D., Booij, J., et al. 2004. Idiopathic hyposmia as a preclinical sign of Parkinson’s disease. Annals of Neurology 56, 173–181.CrossRefGoogle ScholarPubMed

Postuma, R.B., Gagnon, J.F., Montplaisir, J., 2010. Clinical prediction of Parkinson’s disease: planning for the age of neuroprotection. Journal of Neurology, Neurosurgery, & Psychiatry 81, 1008–1013.CrossRefGoogle ScholarPubMed

Postuma, R.B., Gagnon, J.F., Vendette, M., Desjardins, C., Montplaisir, J.Y., 2011. Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Annals of Neurology 69, 811–818.CrossRefGoogle ScholarPubMed

Postuma, R.B., Montplaisir, J., 2010. Transcranial ultrasound and olfaction in REM sleep behavior disorder: testing predictors of Parkinson’s disease. Sleep Med 11, 339–340.CrossRefGoogle ScholarPubMed

Quagliato, L.B., Viana, M.A., Quagliato, E.M., Simis, S., 2009. Olfaction and essential tremor. Arquivos de Neuro-Psiquiatria 67(1), 21–24.CrossRefGoogle ScholarPubMed

Quinn, N.P., Rossor, M.N., Marsden, C.D., 1987. Olfactory threshold in Parkinson’s disease. Journal of Neurology, Neurosurgery, & Psychiatry 50, 88–89.CrossRefGoogle ScholarPubMed

Quinn, N.P., Rossor, M.N., Marsden, C.D., 1987. Olfactory threshold in Parkinson’s disease. Journal of Neurology, Neurosurgery, & Psychiatry 50, 88–89.CrossRefGoogle ScholarPubMed

Rajput, A.H., Gibb, W.R., Zhong, X.H., et al. 1994. Dopa-responsive dystonia: Pathological and biochemical observations in a case. Annals of Neurology 35, 396–402.CrossRefGoogle ScholarPubMed

Rebeck, G.W., Hyman, B.T., 1993. Neuroanatomical connections and specific regional vulnerability in Alzheimer’s disease. Neurobiology of Aging 14(1), 45–47.CrossRefGoogle ScholarPubMed

Reuber, M., Al-Din, A.S., Baborie, A., Chakrabarty, A., 2001. New variant Creutzfeldt-Jakob disease presenting with loss of taste and smell. Journal of Neurology, Neurosurgery, & Psychiatry 71, 412–413.CrossRefGoogle ScholarPubMed

Rial, D., Castro, A.A., Machado, N., et al. 2014. Behavioral phenotyping of Parkin-deficient mice: looking for early preclinical features of Parkinson’s disease. PLoS One 9, e114216.CrossRefGoogle ScholarPubMed

Ritz, B., Lee, P-C., Lassen, C.F., Arah, O.A., 2014. Parkinson disease and smoking revisited Ease of quitting is an early sign of the disease. Neurology, 83(16), 1396–1402.CrossRefGoogle ScholarPubMed

Roberts, R.O., Christianson, T.J., Kremers, W.K., et al. 2016, Association between olfactory dysfunction and amnestic mild cognitive impairment and Alzheimer disease dementia. JAMA Neurology 73, 93–101.CrossRefGoogle ScholarPubMed

Roberts, E., 1986. Alzheimer’s disease may begin in the nose and may be caused by aluminosilicates. Neurobiology of Aging 7, 561–567.CrossRefGoogle ScholarPubMed

Rosenberg, A., Gurevich, T., Mirelman, A., et al. 2011. Multivariate features associated with presence of “severe” mutations in the GBA gene in a cohort of asymptomatic first degree relatives of patient with Parkinson’s disease. Neurology IN4–1.003.Google Scholar

Ross, G.W., Abbott, R.D., Petrovitch, H., Tanner, C.M., White, L.R., 2012. Pre-motor features of Parkinson’s disease: The Honolulu-Asia Aging Study experience. Parkinsonism and Related Disorders 18, 199–202.CrossRefGoogle ScholarPubMed

Ross, G.W., Petrovitch, H., Abbott, R.D., et al. 2004. Parkinsonian signs and substantia nigra neuron density in descendants elders without PD. Annals of Neurology 56, 532–539.CrossRefGoogle Scholar

Ross, G.W., Abbott, R.D., Petrovitch, H., et al. 2006. Association of olfactory dysfunction with incidental Lewy bodies. Movement Disorders 21, 2062–2067.CrossRefGoogle ScholarPubMed

Ross, G.W., Petrovitch, H., Abbott, R.D., et al. 2008. Association of olfactory dysfunction with risk for future Parkinson’s disease. Annals of Neurology 63, 167–173.CrossRefGoogle ScholarPubMed

Royall, D.R., Chiodo, L.K., Polk, M.S., Jaramillo, C.J., 2002. Severe dysosmia is specifically associated with Alzheimer-like memory deficits in nondemented elderly retirees. Neuroepidemiology 21(2), 68–73.CrossRefGoogle ScholarPubMed

Rutty, C.J., 1996. The middle-class plaque: Epidmic polio and the Canadian State, 1936–1937. CBMH/BCHM 13, 277–314.Google Scholar

Sabin, A.B., Olitsky, P.K., Cox, H.R., 1936. Protective action of certain chemicals against infection of monkeys with nasally instelled poliomyelitis virus. Journal of Experimental Medicine 63, 877–892.CrossRefGoogle ScholarPubMed

Sabin, A.B., Ward, R., 1941. The natural history of human poliomyelitis. I. Distribution of virus in nervous and non-nervous tissues. Journal of Experimental Medicine., 73, 771–793.CrossRefGoogle ScholarPubMed

Sagawa, M., Takao, M., Nogawa, S., et al. 2003. [Wilson’s disease associated with olfactory paranoid syndrome and idiopathic thrombocytopenic purpura]. No To Shinkei 55, 899–902.Google ScholarPubMed

Sajjadian, A., Doty, R.L., Gutnick, D., Chirurgi, R.J., Sivak, M., Perl, D., 1994. Olfactory dysfunction in amyotrophic lateral sclerosis. Neurodegeneration 3, 153–157.Google Scholar

Salerno-Kennedy, R., Cusack, S., Cashman, K.D., 2005. Olfactory function in people with genetic risk of dementia. Irish Journal of Medical Science Journal 174, 46–50.Google ScholarPubMed

Salihoglu, M., Kendirli, M.T., Altundag, A., et al. 2014. The effect of obstructive sleep apnea on olfactory functions. Laryngoscope 124, 2190–2194.CrossRefGoogle ScholarPubMed

Samaranch, L., Lorenzo-Betancor, O., Arbelo, J.M., et al. 2010. PINK1-linked parkinsonism is associated with Lewy body pathology. Brain 133, 1128–1142.CrossRefGoogle ScholarPubMed

Sandyk, R., 1981. Olfactory hallucinations in Parkinson’s disease. South African Medical Journal 60, 950.Google ScholarPubMed

Satya-Murti, S., Crisostomo, E. (1988). Olfactory threshold in Friedreich’s ataxia. Muscle & nerve, 11(4), 406–407.Google ScholarPubMed